Table 4 Distribution of children by occurrence of congenital toxoplasmosis according to maternal treatment with spiramycin during pregnancy (2012, Goiânia/ GO, Brazil)
From: Congenital toxoplasmosis and prenatal care state programs
Aspects | Maternal treatment | p | OR (IC) | |||
|---|---|---|---|---|---|---|
Treated | Untreated | |||||
N | % | N | % | |||
1) Clinical type | Â | Â | Â | Â | Â | Â |
 Mild form birth | 57 | 81.4 | 33 | 39.3 |  | 0.148 |
Severe disease at birth | 13 | 18.6 | 51 | 60.7 | <0.001 | (0.070-0.311) |
  Total | 70 | 100.0 | 84 | 100.0 |  |  |
2) Congenital toxoplasmosis | Â | Â | Â | Â | Â | Â |
 Without toxoplasmosis | 50 | 41.7 | 31 | 27.0 | 0.018 | 0.517 |
 Congenital toxoplasmosis | 70 | 58.3 | 84 | 73.0 |  | (0.298-0.895) |
  Total | 120 | 100.0 | 115 | 100.0 |  |  |
3) Severe disease at birth | Â | Â | Â | Â | Â | Â |
 Intracranial calcification | 5 | 38.5 | 6 | 11.8 |  |  |
 Ocular | 2 | 15.4 | 8 | 15.7 |  |  |
 Neuro-optical | 5 | 38.5 | 31 | 60.8 | 0.030 | 0.377 |
 Systemica | 1 | 7.7 | 6 | 11.8 |  | (0.185-0.765) |
  Total | 13 | 100.0 | 51 | 100.0 |  |  |
4) Mild form birth | Â | Â | Â | Â | Â | Â |
 Assimptomatic | 32 | 56.1 | 19 | 57.6 |  |  |
 Meningitis | 20 | 35.1 | 12 | 36.4 | 0.321 | 1.222 |
 Nodal | 1 | 1.8 | 2 | 6.1 |  | (0.678-2.201) |
 Auditory | 4 | 7.0 | 0 | 0.0 |  |  |
  Total | 57 | 100.0 | 33 | 100.0 |  |  |